| imipramine N-oxide reductase | <enzyme> Reduces imipramine n-oxide to imipramine in the presence of menaquinone Registry number: EC 1.7.99.- (26 Jun 1999) |
|---|---|
| indifferent oxide | An oxide that is neither an acid nor a base; e.g., water (hydrogen oxide, H2O). Synonym: indifferent oxide. (05 Mar 2000) |
| oxide | <chemistry> Any element (but especially a metal) that has formed a binary compound with oxygen. (09 Oct 1997) |
| tin oxide | SnO2;used in industry; it is a cause of pneumoconiosis. Synonym: tin oxide. (05 Mar 2000) |
| eserine oxide | An alkaloid from the seed of Physostigma; a parasympathomimetic agent. Synonym: eserine aminoxide, eserine oxide. (05 Mar 2000) |
| ethylene oxide | <chemical> Chemical name: Oxirane (12 Dec 1998) |
| ethyl oxide | CH3CH2OCH2CH3;a flammable, volatile organic solvent used in extraction procedures; formerly widely used as an inhalation anaesthetic; shortcomings include: irritating vapor, slow onset and prolonged recovery phase, explosion hazard. Synonym: ethyl ether, ethyl oxide, sulfuric ether. (05 Mar 2000) |
| zirconium oxide | Used as a coating for the skin in dermatologic pharmaceuticals and as a pigment in paints. (05 Mar 2000) |
| ferric oxide | A compound used as a colouring material. (05 Mar 2000) |
| 4-hydroxyaminoquinoline-1-oxide | <chemical> N-hydroxy-4-quinolineamine 1-oxide. A potent mutagen and carcinogen. It is a reduction product of 4-nitroquinoline-1-oxide. It binds with nucleic acids and inactivates both bacteria and bacteriophage. Pharmacological action: carcinogens, mutagens. Chemical name: 4-Quinolinamine, N-hydroxy-, 1-oxide (12 Dec 1998) |
| 4-nitroquinoline-1-oxide | <chemical> 4-nitroquinoline 1-oxide. A potent mutagen and carcinogen. This compound and its metabolite 4-hydroxyaminoquinoline-1-oxide bind to nucleic acids. It inactivates bacteria but not bacteriophage. Pharmacological action: carcinogens, mutagens. Chemical name: Quinoline, 4-nitro-, 1-oxide (12 Dec 1998) |
| 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | <chemical> 7,8,8a,9a-tetrahydrobenzo(10,11)chryseno (3,4-b)oxirene-7,8-diol. A benzopyrene derivative with carcinogenic and mutagenic activity. Pharmacological action: carcinogens, mutagens. Chemical name: Benzo(10,11)chryseno(3,4-b)oxirene-7,8-diol, 7,8,8a,9a-tetrahydro- (12 Dec 1998) |
| lead oxide | Has been used as an ingredient in external applications such as lead plaster. Synonym: lead oxide (yellow), litharge, massicot. (05 Mar 2000) |
| amorphous insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| butter of zinc | ZnCl2;formerly used as a caustic for the removal of cutaneous cancers, nevi, etc., and in weak solution in the treatment of gonorrhoea and conjunctivitis. Synonym: butter of zinc. (05 Mar 2000) |